Literature DB >> 11912177

Genome-wide linkage analysis of severe, early-onset chronic obstructive pulmonary disease: airflow obstruction and chronic bronchitis phenotypes.

Edwin K Silverman1, Jonathan D Mosley, Lyle J Palmer, Matthew Barth, Jody M Senter, Alison Brown, Jeffrey M Drazen, David J Kwiatkowski, Harold A Chapman, Edward J Campbell, Michael A Province, D C Rao, John J Reilly, Leo C Ginns, Frank E Speizer, Scott T Weiss.   

Abstract

Familial aggregation of chronic obstructive pulmonary disease (COPD) has been demonstrated, but linkage analysis of COPD-related phenotypes has not been reported previously. An autosomal 10 cM genome-wide scan of short tandem repeat (STR) polymorphic markers was analyzed for linkage to COPD-related phenotypes in 585 members of 72 pedigrees ascertained through severe, early-onset COPD probands without severe alpha1-antitrypsin deficiency. Multipoint non-parametric linkage analysis (using the ALLEGRO program) was performed for qualitative phenotypes including moderate airflow obstruction [forced expiratory volume at one second (FEV(1)) < 60% predicted, FEV(1)/FVC < 90% predicted], mild airflow obstruction (FEV(1) < 80% predicted, FEV(1)/FVC < 90% predicted) and chronic bronchitis. The strongest evidence for linkage in all subjects was observed at chromosomes 12 (LOD = 1.70) and 19 (LOD = 1.54) for moderate airflow obstruction, chromosomes 8 (LOD = 1.36) and 19 (LOD = 1.09) for mild airflow obstruction and chromosomes 19 (LOD = 1.21) and 22 (LOD = 1.37) for chronic bronchitis. Restricting analysis to cigarette smokers only provided increased evidence for linkage of mild airflow obstruction and chronic bronchitis to several genomic regions; for mild airflow obstruction in smokers only, the maximum LOD was 1.64 at chromosome 19, whereas for chronic bronchitis in smokers only, the maximum LOD was 2.08 at chromosome 22. On chromosome 12p, 12 additional STR markers were genotyped, which provided additional support for an airflow obstruction locus in that region with a non-parametric multipoint approach for moderate airflow obstruction (LOD = 2.13) and mild airflow obstruction (LOD = 1.43). Using a dominant model with the STR markers on 12p, two point parametric linkage analysis of all subjects demonstrated a maximum LOD score of 2.09 for moderate airflow obstruction and 2.61 for mild airflow obstruction. In smokers only, the maximum two point LOD score for mild airflow obstruction was 3.14. These observations provide suggestive evidence that there is a locus on chromosome 12p which contributes to susceptibility to early-onset COPD.

Entities:  

Mesh:

Year:  2002        PMID: 11912177     DOI: 10.1093/hmg/11.6.623

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  38 in total

1.  "Forward genetics" as a method to maximize power and cost-efficiency in studies of human complex traits.

Authors:  M P M Boks; E M Derks; C V Dolan; R S Kahn; R A Ophoff
Journal:  Behav Genet       Date:  2010-03-16       Impact factor: 2.805

Review 2.  Progress in chronic obstructive pulmonary disease genetics.

Authors:  Edwin K Silverman
Journal:  Proc Am Thorac Soc       Date:  2006-07

3.  Extreme Trait Whole-Genome Sequencing Identifies PTPRO as a Novel Candidate Gene in Emphysema with Severe Airflow Obstruction.

Authors:  Josiah E Radder; Yingze Zhang; Alyssa D Gregory; Shibing Yu; Neil J Kelly; Joseph K Leader; Naftali Kaminski; Frank C Sciurba; Steven D Shapiro
Journal:  Am J Respir Crit Care Med       Date:  2017-07-15       Impact factor: 21.405

4.  Genetic variation in bactericidal/permeability-increasing protein influences the risk of developing rapid airflow decline after hematopoietic cell transplantation.

Authors:  Jason W Chien; Lue Ping Zhao; John A Hansen; Wen Hong Fan; Tanyalak Parimon; Joan G Clark
Journal:  Blood       Date:  2005-11-22       Impact factor: 22.113

5.  A functional mutation in the terminal exon of elastin in severe, early-onset chronic obstructive pulmonary disease.

Authors:  Cassandra M Kelleher; Edwin K Silverman; Thomas Broekelmann; Augusto A Litonjua; Melvin Hernandez; Jody S Sylvia; Joan Stoler; John J Reilly; Harold A Chapman; Frank E Speizer; Scott T Weiss; Robert P Mecham; Benjamin A Raby
Journal:  Am J Respir Cell Mol Biol       Date:  2005-08-04       Impact factor: 6.914

Review 6.  National Emphysema Treatment Trial state of the art: genetics of emphysema.

Authors:  Craig P Hersh; Dawn L DeMeo; Edwin K Silverman
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

Review 7.  Chronic obstructive pulmonary disease. 1: Susceptibility factors for COPD the genotype-environment interaction.

Authors:  A J Sandford; E K Silverman
Journal:  Thorax       Date:  2002-08       Impact factor: 9.139

Review 8.  Integrating genomic and clinical medicine: searching for susceptibility genes in complex lung diseases.

Authors:  Ankit A Desai; Pirro Hysi; Joe G N Garcia
Journal:  Transl Res       Date:  2007-12-18       Impact factor: 7.012

Review 9.  Genetics of chronic obstructive pulmonary disease.

Authors:  Carola Seifart; Alexandra Plagens
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007

10.  Chronic obstructive pulmonary disease: towards pharmacogenetics.

Authors:  Alice M Wood; See Ling Tan; Robert A Stockley
Journal:  Genome Med       Date:  2009-11-30       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.